EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

Comparison of the efficacy of drug‐coated balloon angioplasty and conventional balloon angioplasty in the endovascular treatment of thrombosed arteriovenous dialysis fistulas

Mustafa Ozdemir iD, Onur Taydas iD

Therapeutic Apheresis and Dialysis · 2025

DOI: 10.1111/1744-9987.14197 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Therapeutic Apheresis and Dialysis, 2025. Verfasst von Mustafa Ozdemir und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Sakarya University Faculty of Medicine, Adapazarı, Sakarya, Turkey. Hauptthemen laut MEDLINE: Angioplasty, Balloon, Paclitaxel, Arteriovenous Shunt, Surgical, Renal Dialysis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

To evaluate the efficacy and safety of paclitaxel‐coated balloon angioplasty in the treatment of thrombosed arteriovenous fistulas.

Methods

This prospective, randomized, controlled study investigated the use of drug‐eluting balloons in the treatment of the thrombosis of arteriovenous fistulas (AVFs) at our center between January 2018 and January 2023. A total of 246 patients were included in the study. The mean age of the patients was 61.3 ± 11.5 years. Of the patients, 150 (61%) were male and 96 (39%) were female. Angioplasty was performed using a plain balloon (PB) in 126 patients (51.2%) and a drug‐coated balloon (DCB) in 120 (48.8%). The control images of the patients were obtained at the sixth and 12th months. Patency was evaluated during the follow‐up.

Results

There was no significant difference between the two groups in terms of age, gender, hypertension, hyperlipidemia, diabetes, fistula location, or stenosis length. No significant difference was observed between the groups regarding the number of complications observed during and after the procedure. At the end of the sixth month, the patency rate was found to be 86.7% in the DCB group and 78.6% in the PB group. The 12th‐month patency rate was 77.5% in the DCB group and 57.9% in the PB group. A significant difference was detected between the two groups in relation to the 6th‐ and 12th‐month patency rates ( p = 0.034 and p = 0.046, respectively).

Conclusion

Drug‐coated balloon angioplasty is an effective approach to the treatment of thrombosed AVFs, especially in terms of prolonging primary patency and reducing the need for secondary procedures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angioplasty, BalloonPaclitaxelArteriovenous Shunt, SurgicalRenal DialysisVascular PatencyThrombosisHumansFemaleMaleMiddle AgedProspective StudiesAgedTreatment OutcomeGraft Occlusion, VascularCoated Materials, Biocompatible

Stichwörter der Autor:innen

angioplastyarteriovenous fistuladialysisdrug‐coated balloon

Substanzen

PaclitaxelCoated Materials, Biocompatible

Autor:innen und Institutionen

  • Department of Radiology, Sakarya University Faculty of Medicine, Adapazarı, Sakarya, Turkey.

ORCID-Profile: Mustafa Ozdemir, Onur Taydas

Zitieren

APA

Ozdemir, M., & Taydas, O. (2025). Comparison of the efficacy of drug‐coated balloon angioplasty and conventional balloon angioplasty in the endovascular treatment of thrombosed arteriovenous dialysis fistulas. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14197

Vancouver

Ozdemir M, Taydas O. Comparison of the efficacy of drug‐coated balloon angioplasty and conventional balloon angioplasty in the endovascular treatment of thrombosed arteriovenous dialysis fistulas. Therapeutic Apheresis and Dialysis. 2025. doi:10.1111/1744-9987.14197

BibTeX
@article{Ozdemir2025,
  author = {Ozdemir, Mustafa and Taydas, Onur},
  title = {Comparison of the efficacy of drug‐coated balloon angioplasty and conventional balloon angioplasty in the endovascular treatment of thrombosed arteriovenous dialysis fistulas},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2025},
  doi = {10.1111/1744-9987.14197}
}
Kostenlos starten →